ATE170400T1 - Verwendung von trovafloxacin oder dessen derivaten zur herstellung eines arzneimittels zur behandlung von h.pylori infektionen - Google Patents

Verwendung von trovafloxacin oder dessen derivaten zur herstellung eines arzneimittels zur behandlung von h.pylori infektionen

Info

Publication number: ATE170400T1
Authority: AT; Austria
Prior art keywords: treatment; trovafloxacin; derivatives; production; medicinal product
Prior art date: 1994-04-07

Application number

AT95301959T

Other languages

English (en)

Inventor

Arthur E Girard

Thomas D Gootz

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-07

Filing date

1995-03-23

Publication date

1998-09-15

1995-03-23 Application filed by Pfizer filed Critical Pfizer

1998-09-15 Application granted granted Critical

1998-09-15 Publication of ATE170400T1 publication Critical patent/ATE170400T1/de

Links

208000015181 infectious disease Diseases 0.000 title abstract 2
229940126601 medicinal product Drugs 0.000 title 1
WVPSKSLAZQPAKQ-CDMJZVDBSA-N trovafloxacin Chemical compound C([C@H]1[C@@H]([C@H]1C1)N)N1C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=NC=1N2C1=CC=C(F)C=C1F WVPSKSLAZQPAKQ-CDMJZVDBSA-N 0.000 title 1
229960000497 trovafloxacin Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
241000589989 Helicobacter Species 0.000 abstract 1
208000007107 Stomach Ulcer Diseases 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
239000000654 additive Substances 0.000 abstract 1
230000000996 additive effect Effects 0.000 abstract 1
208000000718 duodenal ulcer Diseases 0.000 abstract 1
230000002496 gastric effect Effects 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT95301959T 1994-04-07 1995-03-23 Verwendung von trovafloxacin oder dessen derivaten zur herstellung eines arzneimittels zur behandlung von h.pylori infektionen ATE170400T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22439294A	1994-04-07	1994-04-07

Publications (1)

Publication Number	Publication Date
ATE170400T1 true ATE170400T1 (de)	1998-09-15

Family

ID=22840476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95301959T ATE170400T1 (de)	1994-04-07	1995-03-23	Verwendung von trovafloxacin oder dessen derivaten zur herstellung eines arzneimittels zur behandlung von h.pylori infektionen

Country Status (5)

Country	Link
EP (1)	EP0676199B1 (de)
AT (1)	ATE170400T1 (de)
DE (1)	DE69504392T2 (de)
DK (1)	DK0676199T3 (de)
ES (1)	ES2121293T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19546249A1 (de) *	1995-12-12	1997-06-19	Bayer Ag	Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19652239A1 (de)	1996-12-16	1998-06-18	Bayer Ag	Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
IN190017B (de)	1999-01-25	2003-05-31	Panacea Biotech Ltd
SE9904108D0 (sv) *	1999-11-15	1999-11-15	New Pharma Research Ab	Nya föreningar
US6576625B2 (en)	2001-03-16	2003-06-10	Panacea Biotic Limited	Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5164402A (en)	1989-08-16	1992-11-17	Pfizer Inc	Azabicyclo quinolone and naphthyridinone carboxylic acids

1995
- 1995-03-23 AT AT95301959T patent/ATE170400T1/de not_active IP Right Cessation
- 1995-03-23 DE DE69504392T patent/DE69504392T2/de not_active Expired - Fee Related
- 1995-03-23 EP EP95301959A patent/EP0676199B1/de not_active Expired - Lifetime
- 1995-03-23 ES ES95301959T patent/ES2121293T3/es not_active Expired - Lifetime
- 1995-03-23 DK DK95301959T patent/DK0676199T3/da active

Also Published As

Publication number	Publication date
EP0676199A1 (de)	1995-10-11
ES2121293T3 (es)	1998-11-16
DK0676199T3 (da)	1999-02-08
DE69504392T2 (de)	1999-02-11
EP0676199B1 (de)	1998-09-02
DE69504392D1 (de)	1998-10-08

Similar Documents

Publication	Publication Date	Title
NO175256C (no)	1994-09-21	Analogifremgangsmåte til fremstilling av terapeutisk aktive 4-oksokinolin-3-karboksylsyrederivater
NO870241L (no)	1987-03-20	Hypoglykemiske tiazolidindioner.
OA09334A (fr)	1992-09-15	"Dérivés d'acides aminés".
ATE102930T1 (de)	1994-04-15	Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
NO933200L (no)	1994-03-10	Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
AU1302388A (en)	1988-09-15	Method of treating anxiety with tetrahydrobenz(c,d)indole-6- carboxamides
DE69413118D1 (de)	1998-10-15	Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
GR3019917T3 (en)	1996-08-31	Benzimidazole derivatives as antimicrobal agent against campylobacter pylon
DE68906200D1 (de)	1993-06-03	Kondensierte pyrazol-3-oxo-propannitril-derivate und verfahren zu deren herstellung.
ATE170400T1 (de)	1998-09-15	Verwendung von trovafloxacin oder dessen derivaten zur herstellung eines arzneimittels zur behandlung von h.pylori infektionen
CA2146414A1 (en)	1995-10-08	Treatment of h. pylori infections
DE3574471D1 (de)	1990-01-04	1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
HUT44767A (en)	1988-04-28	Process for producing new spiro-imidazolidine derivatives
PT84157A (en)	1987-02-01	Process for preparing heptanoyl-glu-asp-ala-amino acid immunostimmulants
DE3787844D1 (de)	1993-11-25	Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen.
DK451687A (da)	1988-05-13	2-guanidino-4-arylthiazol-forbindelser og farmaceutiske praeparater indeholdende disse
ATE183088T1 (de)	1999-08-15	Arzneimittel zur behandlung von hauterkrankungen
MD1687G2 (ro)	2002-03-31	Compuşi ariltio, compoziţie farmaceutică, metode de tratament al infecţiilor bacteriene şi virale
NO934741L (no)	1994-06-24	Fremgangsmåte for minimalisering og kontroll av ischemiske og reperfusjonsskade
ATE113840T1 (de)	1994-11-15	Verwendung einer verbindung zur herstellung eines arzneimittels zur senkung des harnsäuregehalts des blutes.
DE69619088D1 (de)	2002-03-21	Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE40687T1 (de)	1989-02-15	Neue pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE69407042D1 (de)	1998-01-08	Psoralen-derivate, deren herstellung und verwendung als arzneimittel
DE68920022D1 (de)	1995-01-26	Indolessigsäure-derivate, verfahren zur herstellung sowie arzneimittel, die diese als aktive mittel enthalten.
ATE109454T1 (de)	1994-08-15	Catecholaminester.

Legal Events

Date	Code	Title	Description
1999-04-15	UEP	Publication of translation of european patent specification
2005-12-15	REN	Ceased due to non-payment of the annual fee